Showing results (231-240 of 288) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|December 14, 2004
A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivoTatsuki Fukami, Miki Nakajima, Ryoko Yoshida, et al.Pharmacogenetics|April 30, 2004
A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activityHiroyuki Yamanaka, Miki Nakajima, Miki Katoh, et al.Pharmacogenetics and Genomics|September 17, 2008
Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genesTatsuki Fukami, Miki Nakajima, Taiga Maruichi, et al.Journal of Psychiatric Research|December 11, 2017
What can predict and prevent the long-term use of benzodiazepines?Takeo Hata, Tetsufumi Kanazawa, Takeshi Hamada, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2004
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicityTakashi Nozawa, Shigeki Sugiura, Miki Nakajima, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2007
Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoformsRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.The British Journal of Nutrition|September 1, 2012
The citrus flavanone naringenin suppresses CYP1B1 transactivation through antagonising xenobiotic-responsive element bindingChing Ho Poon, Tsz Yan Wong, Yanfei Wang, et al.Pharmacogenetics and Genomics|May 16, 2007
Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patientsMiki Nakajima, Sayaka Komagata, Yuto Fujiki, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2005
In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liverMiki Katoh, Tomohito Matsui, Miki Nakajima, et al.Journal of Lipid Research|August 8, 2025
Chromatin remodeler BRD9 represses transcription of PPARα target genes, including CPT1A to suppress lipid metabolismItsuki Yokoseki, Masataka Nakano, Kiamu Kurosawa, et al.Pageof 29